Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
Fan R, Satilmis H, Vandewalle N, Verheye E, Vlummens P, Maes A, Muylaert C, De Bruyne E, Menu E, Evans H, Chantry A, De Beule N, Hose D, Törngren M, Eriksson H, Vanderkerken K, Maes K, Breckpot K, De Veirman K.
Fan R, et al. Among authors: menu e.
J Immunother Cancer. 2023 Jan;11(1):e005319. doi: 10.1136/jitc-2022-005319.
J Immunother Cancer. 2023.
PMID: 36650020
Free PMC article.